CIK 0001712762 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465211056
- Phone
- 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 4 Open-market buy Chief Financial Officer bought 2,448 shares
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, Chief Sci. & Med. Officer acquired 7,239 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President, CEO bought 16,326 shares
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market buy Executive Chairman bought 40,916 shares
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 4 Open-market buy Director bought 16,326 shares
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
Page 18 of 21 · 401 filings